Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
The Journal of Antimicrobial Chemotherapy|January 7, 2010
Evolution of 2-long terminal repeat (2-LTR) episomal HIV-1 DNA in raltegravir-treated patients and in in vitro infected cellsSandrine Reigadas, Marie-Line Andréola, Linda Wittkop, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 16, 2015
Viremia copy-years as a predictive marker of all-cause mortality in HIV-1-infected patients initiating a protease inhibitor-containing antiretroviral treatmentCatherine Chirouze, Valérie Journot, Vincent Le Moing, et al.The Journal of Antimicrobial Chemotherapy|April 29, 2011
Cellular HIV-1 DNA quantification and short-term and long-term response to antiretroviral therapyBernard Masquelier, Audrey Taieb, Sandrine Reigadas, et al.Annals of the New York Academy of Sciences|December 6, 2006
Anti-HIV activity of steric block oligonucleotidesGabriela Ivanova, Andrey A Arzumanov, John J Turner, et al.Open Forum Infectious Diseases|June 3, 2015
Switch to Rilpivirine/Emtricitabine/Tenofovir Single-Tablet Regimen of Human Immunodeficiency Virus-1 RNA-Suppressed Patients, Agence Nationale de Recherches sur le SIDA et les Hépatites Virales CO3 Aquitaine Cohort, 2012-2014Charles Cazanave, Sandrine Reigadas, Cyril Mazubert, et al.The Journal of Antimicrobial Chemotherapy|January 25, 2024
Use of genotypic HIV DNA testing: a DELPHI-type consensusElisabeth Andre-Garnier, Laurence Bocket, Thomas Bourlet, et al.The Journal of Antimicrobial Chemotherapy|April 15, 2010
HIV-1 resistance patterns to integrase inhibitors in antiretroviral-experienced patients with virological failure on raltegravir-containing regimensDaniel da Silva, Liesbeth Van Wesenbeeck, Dominique Breilh, et al.Plos One|June 26, 2014
Kinetics of HIV-1 CTL epitopes recognized by HLA I alleles in HIV-infected individuals at times near primary infection: the Provir/Latitude45 studyJennifer Papuchon, Patricia Pinson, Gwenda-Line Guidicelli, et al.Plos One|January 30, 2014
Prevalence and evolution of low frequency HIV drug resistance mutations detected by ultra deep sequencing in patients experiencing first line antiretroviral therapy failureMarie-Anne Vandenhende, Pantxika Bellecave, Patricia Recordon-Pinson, et al.Antiviral Therapy|May 25, 2013
Dynamic and rapid changes in viral quasispecies by UDPS in chronic hepatitis C patients receiving telaprevir-based therapyPascale Trimoulet, Patricia Pinson, Jennifer Papuchon, et al.Pageof 4